Session 1: Reflections on Major Milestones in Cancer Research and Technology Development
  • Session Chair: Nancy H. Hopkins, David H. Koch Institute for Integrative Cancer Research at MIT; Amgen, Inc. Professor of Biology, MIT
  • Panel: Robert S. Langer, Jr. ScD '74, David H. Koch Institute for Integrative Cancer Research at MIT; David H. Koch Institute Professor; Professor of Chemical Engineering and Biological Engineering, MIT
  • Jacqueline A. Lees, Associate Director, David H. Koch Institute for Integrative Cancer Research at MIT; Professor of Biology; Ludwig Scholar, MIT
  • Phillip A. Sharp, Institute Professor, David H. Koch Institute for Integrative Cancer Research at MIT
  • Michael S. Goldberg PhD '08, Postdoctoral Associate, David H. Koch Institute for Integrative Cancer Research

Session 1: Reflections on Major Milestones in Cancer Research and Technology Development

Session 2: Engineering Solutions to the Problems of Cancer
  • Session Chair: Paula T. Hammond SB '84 PhD '93, David H. Koch Institute for Integrative Cancer Research at MIT; Bayer Professor and Executive Officer, Department of Chemical Engineering, MIT
  • Panel: Sangeeta N. Bhatia SM '93 PhD '97, David H. Koch Institute for Integrative Cancer Research at MIT; John J. and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science; Director of the Laboratory for Multiscale Regenerative Technologies, MIT; Investigator, Howard Hughes Medical Institute.
  • Joseph DeSimone, Chancellor's Eminent Professor of Chemistry, University of North Carolina at Chapel Hill; William R. Kenan, Jr. Distinguished Professor of Chemical Engineering, North Carolina State University
  • Douglas A. Lauffenburger, Ford Professor of Bioengineering; Head, Department of Biological Engineering, MIT
  • Rebecca L. Ladewski, G, David H. Koch Institute for Integrative Cancer Research at MIT; Department of Chemical Engineering, MIT

Session 2: Engineering Solutions to the Problems of Cancer

Session 3: Paradigm Shifts: From Biology to Technology to Medical Applications
  • Session Chair: Richard O. Hynes PhD '71, David H. Koch Institute for Integrative Cancer Research at MIT; Daniel K. Ludwig Professor for Cancer Research, MIT
  • Panel: Leroy Hood, Affiliate Professor of Immunology, University of Washington, Seattle; President, Institute for Systems Biology
  • Eric S. Lander, Professor of Biology, MIT; Professor of Systems Biology, Harvard Medical School; Founding Director, Broad Institute
  • Susan L. Lindquist, David H. Koch Institute for Integrative Cancer Research at MIT; Professor of Biology, MIT; Member, Whitehead Institute for Biomedical Research; Investigator, Howard Hughes Medical Institute
  • Duaa H. Mohammad PhD '08, Postdoctoral Associate, David H. Koch Institute for Integrative Cancer Research at MIT

Session 3: Paradigm Shifts: From Biology to Technology to Medical Applications

Session 4: Personalized Cancer Care
  • Session Chair: Michael B. Yaffe, David H. Koch Institute for Integrative Cancer Research at MIT; Professor, Departments of Biology and Biological Engineering, MIT; Senior Associate, Broad Institute
  • Panel: Daniel A. Haber SB '77 SM '77, Director, Massachusetts General Hospital Cancer Center; Isselbacher/Schwartz Professor, Harvard Medical School; Investigator, Howard Hughes Medical Institute
  • Michael T. Hemann, David H. Koch Institute for Integrative Cancer Research at MIT; Latham Family Career Development Assistant Professor of Biology, MIT
  • David M. Livingston, Emil Frei Professor of Genetics and Medicine, Harvard Medical School; Deputy Director, Dana-Farber/Harvard Cancer Center; Chief, Charles A. Dana Division of Human Cancer Genetics
  • Corbin Elizabeth Meacham, G, David H. Koch Institute for Integrative Cancer Research at MIT; Department of Biology, MIT

Session 4: Personalized Cancer Care

Watch videos of this symposium

As our faculty and students begin to chart the next course in cancer research, we celebrate the unique role they have played in its history and illustrated how and why MIT researchers are converging their disciplines to conquer cancer.

A series of moderated panel discussions — including top biologists, leading clinical experts, technologists, and biomedical engineers — engaged the audience in exploration of three topics:

  • What were the defining (and teaching) moments in the first three decades of the War on Cancer?
  • How is convergence changing the cancer research paradigm at MIT?
  • What clinical results can we expect to come from the deployment of new approaches to cancer research?

The program took place on Wednesday, March 16, 2011.

In these highly interactive sessions, expert panelists strove to engage the audience in a robust dialogue about the past, present, and future of cancer research. Attendees were encouraged to submit questions in advance and come ready to engage.

Organized by the David H. Koch Institute for Integrative Cancer Research.

Photo courtesy of Tom Ellenberger, Washington University School of Medicine in St. Louis.

 

Read more about this symposium in the news:

MIT News: March 8, 2011

MIT News: March 18, 2011

Slice of MIT


Video archive

Opening and Welcome

  • David A. Mindell PhD '96, Chair, MIT150 Steering Committee; Frances and David Dibner Professor of the History of Engineering and Manufacturing; Professor of Aeronautics and Astronautics; Margaret MacVicar Faculty Fellow; Director, Program in Science, Technology and Society, MIT
  • Susan Hockfield, MIT President and Professor of Neuroscience
  • Tyler E. Jacks, Director David H. Koch Institute for Integrative Cancer Research at MIT; David H. Koch Professor of Biology, MIT; Investigator, Howard Hughes Medical Institute

Session 1: Reflections on Major Milestones in Cancer Research and Technology Development

  • Session Chair: Nancy H. Hopkins, David H. Koch Institute for Integrative Cancer Research at MIT; Amgen, Inc. Professor of Biology, MIT
  • Panel: Robert S. Langer, Jr. ScD '74, David H. Koch Institute for Integrative Cancer Research at MIT; David H. Koch Institute Professor; Professor of Chemical Engineering and Biological Engineering, MIT
  • Jacqueline A. Lees, Associate Director, David H. Koch Institute for Integrative Cancer Research at MIT; Professor of Biology; Ludwig Scholar, MIT
  • Phillip A. Sharp, Institute Professor, David H. Koch Institute for Integrative Cancer Research at MIT
  • Michael S. Goldberg PhD '08, Postdoctoral Associate, David H. Koch Institute for Integrative Cancer Research

 

Session 2: Engineering Solutions to the Problems of Cancer

  • Session Chair: Paula T. Hammond SB '84 PhD '93, David H. Koch Institute for Integrative Cancer Research at MIT; Bayer Professor and Executive Officer, Department of Chemical Engineering, MIT
  • Panel: Sangeeta N. Bhatia SM '93 PhD '97, David H. Koch Institute for Integrative Cancer Research at MIT; John J. and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science; Director of the Laboratory for Multiscale Regenerative Technologies, MIT; Investigator, Howard Hughes Medical Institute.
  • Joseph DeSimone, Chancellor's Eminent Professor of Chemistry, University of North Carolina at Chapel Hill; William R. Kenan, Jr. Distinguished Professor of Chemical Engineering, North Carolina State University
  • Douglas A. Lauffenburger, Ford Professor of Bioengineering; Head, Department of Biological Engineering, MIT
  • Rebecca L. Ladewski, G, David H. Koch Institute for Integrative Cancer Research at MIT; Department of Chemical Engineering, MIT

 

Session 3: Paradigm Shifts: From Biology to Technology to Medical Applications

  • Session Chair: Richard O. Hynes PhD '71, David H. Koch Institute for Integrative Cancer Research at MIT; Daniel K. Ludwig Professor for Cancer Research, MIT
  • Panel: Leroy Hood, Affiliate Professor of Immunology, University of Washington, Seattle; President, Institute for Systems Biology
  • Eric S. Lander, Professor of Biology, MIT; Professor of Systems Biology, Harvard Medical School; Founding Director, Broad Institute
  • Susan L. Lindquist, David H. Koch Institute for Integrative Cancer Research at MIT; Professor of Biology, MIT; Member, Whitehead Institute for Biomedical Research; Investigator, Howard Hughes Medical Institute
  • Duaa H. Mohammad PhD '08, Postdoctoral Associate, David H. Koch Institute for Integrative Cancer Research at MIT

 

Session 4: Personalized Cancer Care

  • Session Chair: Michael B. Yaffe, David H. Koch Institute for Integrative Cancer Research at MIT; Professor, Departments of Biology and Biological Engineering, MIT; Senior Associate, Broad Institute
  • Panel: Daniel A. Haber SB '77 SM '77, Director, Massachusetts General Hospital Cancer Center; Isselbacher/Schwartz Professor, Harvard Medical School; Investigator, Howard Hughes Medical Institute
  • Michael T. Hemann, David H. Koch Institute for Integrative Cancer Research at MIT; Latham Family Career Development Assistant Professor of Biology, MIT
  • David M. Livingston, Emil Frei Professor of Genetics and Medicine, Harvard Medical School; Deputy Director, Dana-Farber/Harvard Cancer Center; Chief, Charles A. Dana Division of Human Cancer Genetics
  • Corbin Elizabeth Meacham, G, David H. Koch Institute for Integrative Cancer Research at MIT; Department of Biology, MIT

Wednesday March 16, 2011

Continental breakfast and registration

7:30 - 8:30 am

Opening and Welcome

8:30-9 am

  • David A. Mindell PhD '96, Chair, MIT150 Steering Committee and Dibner Professor of the History of Engineering and Manufacturing and of Aeronautics and Astronautics, MIT
  • Susan Hockfield
, President, MIT
  • Tyler E. Jacks

, Director, David H. Koch Institute for Integrative Cancer Research; David H. Koch Professor of Biology, MIT

Reflections on Major Milestones in Cancer Research and Technology Development

9-10:30 am

Session Chair: Nancy H. Hopkins, Amgen, Inc. Professor of Biology, MIT

  • Phillip A. Sharp
, Institute Professor, MIT
  • Jacqueline A. Lees
, Associate Director, David H. Koch Institute for Integrative Cancer Research and Professor of Biology, MIT
  • Robert S. Langer, Jr. ScD '74
, Institute Professor and Professor of Chemical Engineering and Biological Engineering, MIT

Group discussion including Michael Goldberg PhD '08, Postdoctoral Associate, David H. Koch Institute for Integrative Cancer Research

15 minute break



Engineering Solutions to the Problems of Cancer

10:45 am-12:15 pm

Session Chair: Paula T. Hammond '84 PhD '93, Bayer Chair Professor of Chemical Engineering, MIT

  • Sangeeta N. Bhatia SM '93 PhD '97, Professor of Health Sciences and Technology and Professor of Electrical Engineering and Computer Science, MIT
  • Joseph DeSimone
, Chancellor’s Eminent Professor of Chemistry, University of North Carolina William R. Kenan, Jr. Distinguished Professor of Chemical Engineering, North Carolina State University
  • Douglas A. Lauffenburger, Ford Professor and Head of the Department of Biological Engineering, MIT

Group discussion including Rebecca Ladewski, G, David H. Koch Institute for Integrative Cancer Research



Lunch 12:15-1:30



Paradigm Shifts: From Biology to Technology to Medical Applications

1:30-3 pm

Session Chair: Richard O. Hynes PhD '71, Daniel K. Ludwig Professor for Cancer Research, MIT

  • Eric S. Lander
, Professor of Biology, MIT; Professor of Systems Biology, Harvard Medical School; Founding Director, The Broad Institute of MIT and Harvard
  • 
Lee Hood, 

Affiliate Professor of Immunology, University of Washington; President, Institute of Systems Biology
  • Susan L. Lindquist, Professor of Biology, MIT

Group discussion including Duaa Mohammad PhD '08, Postdoctoral Associate, David H. Koch Institute for Integrative Cancer Research

15 minute break

Personalized Cancer Care

3:15-4:45 pm

Session Chair: Michael B. Yaffe, Professor of Biology, MIT

  • Michael T. Hemann, Latham Family Career Development Assistant Professor of Biology, MIT
  • David M. Livingston
, Emil Frei Professor of Genetics and Medicine, Harvard Medical School
  • 
Daniel A. Haber '77 SM 77, Laurel Schwartz Professor of Medicine, Harvard Medical School; Director, Center for Cancer Risk Analysis, MGH; Director, MGH Cancer Center, MGH

Group discussion including Corbin Meacham, G, David H. Koch Institute for Integrative Cancer Research

Closing Comments

4:45 - 4:55 pm

  • Tyler E. Jacks, Director, David H. Koch Institute for Integrative Cancer Research; David H. Koch Professor of Biology